![](https://investorshub.advfn.com/uicon/8777.png?cb=1703671008)
Thursday, January 12, 2023 9:30:53 AM
Under the new operating structure, Genefic (formerly Dalrada Health) will be separated from the other wholly-owned subsidiaries of Dalrada: Dalrada Energy Services, Dalrada Technologies, and Dalrada Precision Manufacturing. This will allow for anticipated growth in each respective sector. Further, it will allow each individual sector to focus on product and technology development, while simultaneously ensuring Genefic can concentrate its efforts solely on the healthcare market. Genefic will continue to be 100% owned by DFCO, with financial reporting to remain unchanged.
“I am pleased to announce a new operating model to prepare and support the exponential growth of Dalrada Health,” said Brian Bonar, Dalrada’s Founder and Chief Executive Officer. “At this time, Dalrada Health will assume the name ‘Genefic.’ Additional changes will include a new board structure, an appointment of a Chief Executive Officer and Chief Operating Officer (both of which are expected to be made from the existing management pool), a new operating location, and a new website. All of these changes are specifically designed to support the new company in its mission, goals, and services.”
Mr. Bonar continued, “Genefic will focus on improving health outcomes for people around the world through reimagined patient care. This will be achieved by employing the latest technological advances and redesigning current staffing and health care work models, among others.”
Recent DFCO News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 07:39:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:18:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 10:19:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 11:25:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 02:51:49 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/19/2023 07:57:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 09:06:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 12:01:32 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 11:53:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/22/2023 09:23:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 06:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:15:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 08:13:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/13/2023 11:59:05 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM